The hormone/glucose ratios in NAFLD patients (Figure 14A) and T2DM patients (Figure 14B) have been obtained from published data of plasma insulin, glucagon, GLP-1 and glucose concentrations70. This evidence concerns the gene GLP1R and metabolic dysfunction-associated steatotic liver disease.